To: Crossy who wrote (24754 ) 11/8/2006 2:11:15 PM From: jayt Read Replies (2) | Respond to of 37387 Of course I found this stuff using "the google." ************** In April 2004, the publisher of StockLemon.com told The Wall Street Journal that his name is Andrew Left, and that he's a stock trader based in Southern California. ********************** Danks' suit also seeks to strip a purported veil of anonymity from StockLemon.com's principals, as well as "the true identities of the fictitious names of the people who post." Andrew Left, the Los Angeles-based stock researcher who founded the site, finds that claim disingenuous, pointing to an on-site disclaimer accompanying items about iMergent that notes "the principles of StockLemon.com might hold a position in any of the securities profiled on the site." "I've disclosed that from Day One," said Left, who confirms he holds a "short" position on iMergent stock. "I take my personal research and put true information online on my Web log." He acknowledged posting anonymously, but said he readily identified himself to iMergent when asked. "I e-mailed Don Danks two weeks ago to confirm who I was, to tell him where to contact my lawyer so he could serve me," Left said. Left also confirmed Wednesday that he authored statements on StockLemon.com that, among other things, dismiss Danks' suit as an effort to use the courts to suppress critical commentary on iMergent. "Mr. Danks has decided to sue [StockLemon.com] for publishing what we believe to be the truth. Neither Mr. Danks or iMergent has ever contacted [StockLemon.com] to correct any statements that have been published," he wrote. "[StockLemon.com] believes that iMergent Inc. is not only attempting to deceive it potential customers through a variety of channels, but it is also trying to deceive the investment community by fostering an image of its corporate history and business model that is inconsistent with documented facts," the statement adds. Danks countered that StockLemon.com's commentary about him has been "false, misleading and . . . emotionally and financially devastating to me, my family, employees of iMergent as well as the majority of stockholders of iMergent." There is no doubt StockLemon.com's comments have been sharp. It labeled iMergent as the "worst" of the companies it has reviewed, referring to Danks as "a pathological CEO" for alleged misleading statements about his company operations. "[iMergent's] business model is a joke, the balance sheet is a joke, the management is a joke," the site says. "Unfortunately, the money lost by gullible customers is real." Danks said he intends to clear his name, insisting he has conducted his "entire professional career honestly and ethically. . . . To be personally targeted like this by StockLemon.com will not be tolerated."